Tumor-Associated Myeloid Cells in Cancer Progression

[1]  C. Drake,et al.  Immunotherapy in Prostate Cancer: Teaching an Old Dog New Tricks , 2018, Current Oncology Reports.

[2]  Wen-Chao Liu,et al.  Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors , 2018, Cell Death & Disease.

[3]  G. Adema,et al.  Interactions among myeloid regulatory cells in cancer , 2018, Cancer Immunology, Immunotherapy.

[4]  M. Shaul,et al.  Cancer‐related circulating and tumor‐associated neutrophils – subtypes, sources and function , 2018, The FEBS journal.

[5]  J. Utikal,et al.  Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors , 2018, Front. Immunol..

[6]  L. Kwak,et al.  Targeting myeloid-derived suppressor cells for cancer immunotherapy , 2018, Cancer Immunology, Immunotherapy.

[7]  Peng Zhang,et al.  Tumor-derived exosomes induce PD1+ macrophage population in human gastric cancer that promotes disease progression , 2018, Oncogenesis.

[8]  Bin Zhang,et al.  Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic ductal adenocarcinoma , 2018, Cell Death & Disease.

[9]  D. Gabrilovich,et al.  Plasticity of myeloid-derived suppressor cells in cancer. , 2018, Current opinion in immunology.

[10]  Huaxi Xu,et al.  Immunosuppressive Role of Myeloid-Derived Suppressor Cells and Therapeutic Targeting in Lung Cancer , 2018, Journal of immunology research.

[11]  Y. Kienast,et al.  Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity , 2018, The Journal of experimental medicine.

[12]  J. Utikal,et al.  Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression , 2018, Front. Immunol..

[13]  L. Tai,et al.  Phosphodiesterase-5 inhibition reduces postoperative metastatic disease by targeting surgery-induced myeloid derived suppressor cell-dependent inhibition of Natural Killer cell cytotoxicity , 2018, Oncoimmunology.

[14]  C. Rosales.  Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types? , 2018, Front. Physiol..

[15]  M. Poidinger,et al.  The tumour microenvironment creates a niche for the self-renewal of tumour-promoting macrophages in colon adenoma , 2018, Nature Communications.

[16]  P. Murray.  Nonresolving macrophage‐mediated inflammation in malignancy , 2018, The FEBS journal.

[17]  A. Sica,et al.  Tumor‐associated myeloid cells: new understandings on their metabolic regulation and their influence in cancer immunotherapy , 2018, The FEBS journal.

[18]  C. Fenselau,et al.  Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment , 2018, The Journal of Immunology.

[19]  J. Qin,et al.  Blockade of CCR5-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy in gastric cancer , 2018, Immunopharmacology and immunotoxicology.

[20]  David M. Woods,et al.  The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy , 2018, Cancer Immunology, Immunotherapy.

[21]  D. Gabrilovich,et al.  Myeloid-derived suppressor cells coming of age , 2018, Nature Immunology.

[22]  M. Merad,et al.  Macrophages orchestrate breast cancer early dissemination and metastasis , 2018, Nature Communications.

[23]  Rui Zhang,et al.  Inhibition of IL-18-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy against osteosarcoma cancer , 2017, Journal of bone oncology.

[24]  M. Netea,et al.  Cellular metabolism of tumor‐associated macrophages – functional impact and consequences , 2017, FEBS letters.

[25]  K. Yaddanapudi,et al.  Myeloid‐derived suppressor cells—a new therapeutic target to overcome resistance to cancer immunotherapy , 2017, Journal of leukocyte biology.

[26]  Jingqin Luo,et al.  Tissue‐Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression , 2017, Immunity.

[27]  H. Kubo,et al.  Primary Tumors Limit Metastasis Formation through Induction of IL15-Mediated Cross-Talk between Patrolling Monocytes and NK Cells , 2017, Cancer Immunology Research.

[28]  A. Al-Khami,et al.  Energy metabolic pathways control the fate and function of myeloid immune cells , 2017, Journal of leukocyte biology.

[29]  P. Ordentlich,et al.  Entinostat Neutralizes Myeloid-Derived Suppressor Cells and Enhances the Antitumor Effect of PD-1 Inhibition in Murine Models of Lung and Renal Cell Carcinoma , 2017, Clinical Cancer Research.

[30]  G. Fernández,et al.  Novel Use of All-Trans-Retinoic Acid in A Model of Lipopolysaccharide-Immunosuppression to Decrease the Generation of Myeloid-Derived Suppressor Cells by Reducing the Proliferation of CD34+ Precursor Cells , 2017, Shock.

[31]  S. Mabuchi,et al.  The significance of tumor-associated neutrophil density in uterine cervical cancer treated with definitive radiotherapy. , 2017, Gynecologic oncology.

[32]  Xiao-dong Zhu,et al.  Colony-Stimulating Factor 1 Receptor Blockade Inhibits Tumor Growth by Altering the Polarization of Tumor-Associated Macrophages in Hepatocellular Carcinoma , 2017, Molecular Cancer Therapeutics.

[33]  Julian A. Kim,et al.  Nanoparticle Systems Modulating Myeloid-Derived Suppressor Cells for Cancer Immunotherapy. , 2017, Current topics in medicinal chemistry.

[34]  Daniel M. Corey,et al.  PD-1 expression by tumor-associated macrophages inhibits phagocytosis and tumor immunity , 2017, Nature.

[35]  N. Bardeesy,et al.  The Presence of Interleukin-13 at Pancreatic ADM/PanIN Lesions Alters Macrophage Populations and Mediates Pancreatic Tumorigenesis. , 2017, Cell reports.

[36]  Shinichi Sato,et al.  CXCL17 Attenuates Imiquimod-Induced Psoriasis-like Skin Inflammation by Recruiting Myeloid-Derived Suppressor Cells and Regulatory T Cells , 2017, The Journal of Immunology.

[37]  Luis E. Arias-Romero,et al.  Lack of STAT6 Attenuates Inflammation and Drives Protection against Early Steps of Colitis-Associated Colon Cancer , 2017, Cancer Immunology Research.

[38]  P. Pandolfi,et al.  MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia. , 2017, Blood.

[39]  Theresa A. Storm,et al.  Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors , 2017, Science Translational Medicine.

[40]  Ting Wu,et al.  Tumor microenvironment and therapeutic response. , 2017, Cancer letters.

[41]  J. Xavier,et al.  Metabolic origins of spatial organization in the tumor microenvironment , 2017, Proceedings of the National Academy of Sciences.

[42]  M. Kortylewski,et al.  Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities , 2017, Cancer Immunology, Immunotherapy.

[43]  R. Kiessling,et al.  Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma , 2017, Oncotarget.

[44]  A. M. Houghton,et al.  Neutrophils dominate the immune cell composition in non-small cell lung cancer , 2017, Nature Communications.

[45]  Jieying Chen,et al.  Suppression of T cells by myeloid-derived suppressor cells in cancer. , 2017, Human immunology.

[46]  Alberto Mantovani,et al.  Tumour-associated macrophages as treatment targets in oncology , 2017, Nature Reviews Clinical Oncology.

[47]  Y. Sakamoto,et al.  Elevated preoperative neutrophil-to-lymphocytes ratio predicts poor prognosis after esophagectomy in T1 esophageal cancer , 2017, International Journal of Clinical Oncology.

[48]  K. Leandersson,et al.  On the origin of myeloid-derived suppressor cells , 2016, Oncotarget.

[49]  Jingqin Luo,et al.  Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression. , 2017, Immunity.

[50]  Kimberly R. Jordan,et al.  Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients , 2017, Cancer Immunology, Immunotherapy.

[51]  P. Shah,et al.  Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis , 2017, Breast Cancer Research.

[52]  N. Hamidi,et al.  Role of neutrophil-to-lymphocyte ratio in prediction of Gleason score upgrading and disease upstaging in low-risk prostate cancer patients eligible for active surveillance. , 2016, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[53]  R. Roden,et al.  RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells , 2016, Oncotarget.

[54]  S. Singhal,et al.  Tumor-associated neutrophils display a distinct N1 profile following TGFβ modulation: A transcriptomics analysis of pro- vs. antitumor TANs , 2016, Oncoimmunology.

[55]  R. Orentas,et al.  Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for Sarcomas , 2016, Cancer Immunology Research.

[56]  Xiaoping Chen,et al.  Implications of MDSCs-targeting in lung cancer chemo-immunotherapeutics. , 2016, Pharmacological research.

[57]  C. Garlanda,et al.  Occurrence and significance of tumor‐associated neutrophils in patients with colorectal cancer , 2016, International journal of cancer.

[58]  Hongsheng Wang,et al.  TGF-β induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype , 2016, Oncotarget.

[59]  Peter J. Murray,et al.  Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards , 2016, Nature Communications.

[60]  I. Weissman,et al.  CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer. , 2016, The Journal of clinical investigation.

[61]  K. E. Visser,et al.  Neutrophils in cancer: neutral no more , 2016, Nature Reviews Cancer.

[62]  A. Chang,et al.  Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling. , 2016, Cancer research.

[63]  Eric C. Holland,et al.  The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas , 2016, Science.

[64]  E. Diamandis,et al.  Cancer immunotherapy: the beginning of the end of cancer? , 2016, BMC Medicine.

[65]  A. Giatromanolaki,et al.  Gradient Infiltration of Neutrophil Extracellular Traps in Colon Cancer and Evidence for Their Involvement in Tumour Growth , 2016, PloS one.

[66]  Hui Zhang,et al.  Nanoparticle Targeting of Neutrophils for Improved Cancer Immunotherapy , 2016, Advanced healthcare materials.

[67]  B. Schilling,et al.  Type I IFNs induce anti‐tumor polarization of tumor associated neutrophils in mice and human , 2016, International journal of cancer.

[68]  N. Enomoto,et al.  Performance status and neutrophil-lymphocyte ratio are important prognostic factors in elderly patients with unresectable pancreatic cancer. , 2016, Journal of gastrointestinal oncology.

[69]  M. Cassatella,et al.  Neutrophil-derived chemokines on the road to immunity , 2016, Seminars in Immunology.

[70]  D. Gabrilovich,et al.  The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. , 2016, Trends in immunology.

[71]  M. Kaplan,et al.  At the Bench: Neutrophil extracellular traps (NETs) highlight novel aspects of innate immune system involvement in autoimmune diseases , 2016, Journal of leukocyte biology.

[72]  Davalyn R. Powell,et al.  Neutrophils in the Tumor Microenvironment. , 2016, Trends in immunology.

[73]  Y. Sakamoto,et al.  Neutrophil/lymphocyte ratio predicts the prognosis in esophageal squamous cell carcinoma patients , 2016, Surgery Today.

[74]  E. Uribe-Querol,et al.  Neutrophils in Cancer: Two Sides of the Same Coin , 2015, Journal of immunology research.

[75]  I. Malanchi,et al.  Neutrophils support lung colonization of metastasis-initiating breast cancer cells , 2015, Nature.

[76]  S. Dey,et al.  Neutrophils Oppose Uterine Epithelial Carcinogenesis via Debridement of Hypoxic Tumor Cells. , 2015, Cancer cell.

[77]  Young-sil Yoon,et al.  CREB pathway links PGE2 signaling with macrophage polarization , 2015, Proceedings of the National Academy of Sciences.

[78]  D. Metzger,et al.  Patrolling monocytes control tumor metastasis to the lung , 2015, Science.

[79]  Z. Granot,et al.  Plasticity beyond cancer cells and the "immunosuppressive switch". , 2015, Cancer research.

[80]  Jing-quan Li,et al.  Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma , 2015, Gut.

[81]  D. Gabrilovich,et al.  Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. , 2015, The Journal of clinical investigation.

[82]  Ash A. Alizadeh,et al.  Abstract PR09: The prognostic landscape of genes and infiltrating immune cells across human cancers , 2015 .

[83]  W. Garrett,et al.  CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function , 2015, Cell reports.

[84]  J. Pollard,et al.  CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages , 2015, The Journal of experimental medicine.

[85]  S. Nourshargh,et al.  Leukotriene B4-Neutrophil Elastase Axis Drives Neutrophil Reverse Transendothelial Cell Migration In Vivo , 2015, Immunity.

[86]  Han Liu,et al.  CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3–72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis , 2015, Oncotarget.

[87]  L. Terracciano,et al.  Absence of myeloperoxidase and CD8 positive cells in colorectal cancer infiltrates identifies patients with severe prognosis , 2015, Oncoimmunology.

[88]  W. Zou,et al.  Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies , 2015, Cancer Immunology Research.

[89]  E. R. Sutherland,et al.  CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease. , 2015, American journal of respiratory and critical care medicine.

[90]  P. Allavena,et al.  The interaction of anticancer therapies with tumor-associated macrophages , 2015, The Journal of experimental medicine.

[91]  C. Garlanda,et al.  PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer , 2015, Cell.

[92]  Je-in Youn,et al.  Regulation of tumor metastasis by myeloid-derived suppressor cells. , 2015, Annual review of medicine.

[93]  T. Welling,et al.  Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells. , 2014, Gastroenterology.

[94]  Hyun-Jong Cho,et al.  Elevated endoplasmic reticulum stress reinforced immunosuppression in the tumor microenvironment via myeloid-derived suppressor cells , 2014, Oncotarget.

[95]  J. Quigley,et al.  Tissue-Infiltrating Neutrophils Constitute the Major In Vivo Source of Angiogenesis-Inducing MMP-9 in the Tumor Microenvironment12 , 2014, Neoplasia.

[96]  Robin L. Anderson,et al.  BMP4 inhibits breast cancer metastasis by blocking myeloid-derived suppressor cell activity. , 2014, Cancer research.

[97]  H. Fiegl,et al.  In situ proliferation contributes to accumulation of tumor‐associated macrophages in spontaneous mammary tumors , 2014, European journal of immunology.

[98]  Jeffrey W Pollard,et al.  Tumor-associated macrophages: from mechanisms to therapy. , 2014, Immunity.

[99]  Charles N. Serhan,et al.  Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.

[100]  V. Bronte,et al.  Myeloid‐derived suppressor cell heterogeneity in human cancers , 2014, Annals of the New York Academy of Sciences.

[101]  Ben Tran,et al.  Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. , 2014, Journal of the National Cancer Institute.

[102]  Will Liao,et al.  The cellular and molecular origin of tumor-associated macrophages , 2014, Science.

[103]  K. Matsushima,et al.  Tracking of intertissue migration reveals the origins of tumor-infiltrating monocytes , 2014, Proceedings of the National Academy of Sciences.

[104]  S. Weiss,et al.  CXCR2‐mediated tumor‐associated neutrophil recruitment is regulated by IFN‐β , 2014, International journal of cancer.

[105]  T. Mayadas,et al.  The multifaceted functions of neutrophils. , 2014, Annual review of pathology.

[106]  M. Cassatella,et al.  Neutrophil-derived cytokines involved in physiological and pathological angiogenesis. , 2014, Chemical immunology and allergy.

[107]  D. Schadendorf,et al.  Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A–Specific T Cells , 2013, Clinical Cancer Research.

[108]  C. Garlanda,et al.  Tumor associated macrophages and neutrophils in cancer. , 2013, Immunobiology.

[109]  Kimberly R. Jordan,et al.  Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients , 2013, Cancer Immunology, Immunotherapy.

[110]  A. Mócsai.  Diverse novel functions of neutrophils in immunity, inflammation, and beyond , 2013, The Journal of experimental medicine.

[111]  F. Donskov.  Immunomonitoring and prognostic relevance of neutrophils in clinical trials. , 2013, Seminars in cancer biology.

[112]  C. Murdoch,et al.  Neutrophil-mediated tumour angiogenesis: subversion of immune responses to promote tumour growth. , 2013, Seminars in cancer biology.

[113]  L. Terracciano,et al.  High Myeloperoxidase Positive Cell Infiltration in Colorectal Cancer Is an Independent Favorable Prognostic Factor , 2013, PloS one.

[114]  A. Grosso,et al.  Protective Role of the Inflammatory CCR2/CCL2 Chemokine Pathway through Recruitment of Type 1 Cytotoxic γδ T Lymphocytes to Tumor Beds , 2013, The Journal of Immunology.

[115]  P. Kubes,et al.  Neutrophil recruitment and function in health and inflammation , 2013, Nature Reviews Immunology.

[116]  A. Palucka,et al.  Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet? , 2013, Science.

[117]  P. Schirmacher,et al.  Epithelial-to-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma and Pancreatic Tumor Cell Lines: The Role of Neutrophils and Neutrophil-Derived Elastase , 2012, Clinical & developmental immunology.

[118]  P. Sinha,et al.  Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression. , 2012, Seminars in cancer biology.

[119]  A. Aguzzi,et al.  Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway. , 2012, Cancer cell.

[120]  V. Seshan,et al.  A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis , 2012, Cell.

[121]  S. Lang,et al.  Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology , 2012, Cancer Immunology, Immunotherapy.

[122]  N. Jhala,et al.  Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. , 2012, Cancer cell.

[123]  Katsumasa Takahashi,et al.  Immunosuppressive activity of CD14+ HLA‐DR− cells in squamous cell carcinoma of the head and neck , 2012, Cancer science.

[124]  H. Møller,et al.  Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma , 2012, Cancer.

[125]  P. Sinha,et al.  Regulating the suppressors: apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC) , 2012, Cancer Immunology, Immunotherapy.

[126]  A. Zychlinsky,et al.  Neutrophil function: from mechanisms to disease. , 2012, Annual review of immunology.

[127]  D. Gabrilovich,et al.  Coordinated regulation of myeloid cells by tumours , 2012, Nature Reviews Immunology.

[128]  Douglas Hanahan,et al.  Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment Prospects and Obstacles for Therapeutic Targeting of Function-enabling Stromal Cell Types , 2022 .

[129]  M. Karin,et al.  NF‐κB and the link between inflammation and cancer , 2012, Immunological reviews.

[130]  A. Mantovani,et al.  Cancer-related inflammation: common themes and therapeutic opportunities. , 2012, Seminars in cancer biology.

[131]  Y. Zeng,et al.  Increased Intratumoral Neutrophil in Colorectal Carcinomas Correlates Closely with Malignant Phenotype and Predicts Patients' Adverse Prognosis , 2012, PloS one.

[132]  D. Kuang,et al.  Neutrophils promote motility of cancer cells via a hyaluronan‐mediated TLR4/PI3K activation loop , 2011, The Journal of pathology.

[133]  L. Norton,et al.  Tumor entrained neutrophils inhibit seeding in the premetastatic lung. , 2011, Cancer cell.

[134]  J. Quigley,et al.  Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation. , 2011, The American journal of pathology.

[135]  T. Whiteside,et al.  Tumor‐derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation , 2011, International journal of cancer.

[136]  Olca Basturk,et al.  Tumor-infiltrating neutrophils in pancreatic neoplasia , 2011, Modern Pathology.

[137]  Alberto Mantovani,et al.  Neutrophils in the activation and regulation of innate and adaptive immunity , 2011, Nature Reviews Immunology.

[138]  S. Lang,et al.  Peripheral Blood Neutrophil Granulocytes from Patients with Head and Neck Squamous Cell Carcinoma Functionally Differ from Their Counterparts in Healthy Donors , 2011, International journal of immunopathology and pharmacology.

[139]  Jinghang Zhang,et al.  CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis , 2011, Nature.

[140]  Xiao‐Yu Yin,et al.  Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. , 2011, Journal of hepatology.

[141]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[142]  E. Hirsch,et al.  Regulating neutrophil apoptosis: new players enter the game. , 2011, Trends in immunology.

[143]  S. Weiss,et al.  Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. , 2010, The Journal of clinical investigation.

[144]  R. Godschalk,et al.  Genotoxic effects of neutrophils and hypochlorous acid. , 2010, Mutagenesis.

[145]  A. M. Houghton,et al.  Neutrophil Elastase-Mediated Degradation of IRS-1 Accelerates Lung Tumor Growth , 2010, Nature Medicine.

[146]  N. Marcussen,et al.  Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[147]  G. Cheng,et al.  Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. , 2009, Cancer cell.

[148]  Alberto Mantovani,et al.  Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. , 2009, Carcinogenesis.

[149]  P. Sinha,et al.  Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer 1 , 2009, The Journal of Immunology.

[150]  Srinivas Nagaraj,et al.  Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.

[151]  Xuetao Cao,et al.  Cancer-Expanded Myeloid-Derived Suppressor Cells Induce Anergy of NK Cells through Membrane-Bound TGF-β11 , 2009, The Journal of Immunology.

[152]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[153]  A. Mantovani,et al.  Cancer: Inflaming metastasis , 2008, Nature.

[154]  P. Sinha,et al.  Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. , 2007, Cancer research.

[155]  M. Colombo,et al.  The terminology issue for myeloid-derived suppressor cells. , 2007, Cancer research.

[156]  D. Gabrilovich,et al.  Role Of Immature Myeloid Cells in Mechanisms of Immune Evasion In Cancer , 2006, Cancer Immunology, Immunotherapy.

[157]  V. Bronte,et al.  Regulation of immune responses by L-arginine metabolism , 2005, Nature Reviews Immunology.

[158]  Li Li,et al.  Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.

[159]  M. Pagano,et al.  Prognostic Value of Intratumoral Neutrophils in Advanced Gastric Carcinoma in a High-Risk Area in Northern Italy , 2002, Modern Pathology.

[160]  G. Ricevuti,et al.  Neutrophil infiltration into human gliomas , 1999, Acta Neuropathologica.

[161]  A. Mantovani,et al.  A paracrine circuit in the regulation of the proliferation of macrophages infiltrating murine sarcomas. , 1990, Journal of immunology.